GemPharmatech (SH:688046) Zheng Quan Zhi Xing·2025-07-04 16:35Core Viewpoint - The company is implementing a differentiated dividend distribution plan, which involves special handling of ex-rights and ex-dividend dates, in accordance with relevant laws and regulations [1][7]. Group 1: Reasons for Differentiated Dividend - The company approved a share repurchase plan using its own or self-raised funds, with a total repurchase amount between RMB 22 million and RMB 40 million, at a price not exceeding RMB 18 per share [2]. - The repurchased shares will be used for employee stock ownership plans or equity incentives, with a repurchase period of 12 months from the board's approval [2]. Group 2: Differentiated Dividend Plan - The company held its annual general meeting on May 28, 2025, and approved a profit distribution plan, proposing to distribute cash dividends of RMB 1.10 per 10 shares (including tax) [4]. - The total share capital of the company is 410 million shares, with 1,009,362 shares held in the repurchase account, leading to a base for cash dividend distribution of 408,990,638 shares [4]. Group 3: Calculation Basis for Differentiated Dividend - The company will only distribute cash dividends without capital reserve transfers or stock dividends, resulting in no change in circulating shares [4]. - The ex-rights and ex-dividend reference price calculations show minimal impact, with the absolute value of the impact being less than 1% [5].